DE69034053T2 - Transformation von tierischen somatischen zellen mittels partikeln - Google Patents

Transformation von tierischen somatischen zellen mittels partikeln

Info

Publication number
DE69034053T2
DE69034053T2 DE69034053T DE69034053T DE69034053T2 DE 69034053 T2 DE69034053 T2 DE 69034053T2 DE 69034053 T DE69034053 T DE 69034053T DE 69034053 T DE69034053 T DE 69034053T DE 69034053 T2 DE69034053 T2 DE 69034053T2
Authority
DE
Germany
Prior art keywords
animals
transformation
particle
somatic cells
spark discharge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69034053T
Other languages
English (en)
Other versions
DE69034053D1 (de
Inventor
J Brill
E Mccabe
Ning-Sun Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27005554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69034053(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Application granted granted Critical
Publication of DE69034053D1 publication Critical patent/DE69034053D1/de
Publication of DE69034053T2 publication Critical patent/DE69034053T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Electromagnetism (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DE69034053T 1989-06-26 1990-06-21 Transformation von tierischen somatischen zellen mittels partikeln Revoked DE69034053T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37186989A 1989-06-26 1989-06-26
US49493390A 1990-03-14 1990-03-14
PCT/US1990/003522 WO1991000359A1 (en) 1989-06-26 1990-06-21 Particle-mediated transformation of animal somatic cells

Publications (2)

Publication Number Publication Date
DE69034053D1 DE69034053D1 (de) 2003-04-30
DE69034053T2 true DE69034053T2 (de) 2003-12-04

Family

ID=27005554

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69034053T Revoked DE69034053T2 (de) 1989-06-26 1990-06-21 Transformation von tierischen somatischen zellen mittels partikeln

Country Status (10)

Country Link
US (2) US20020081739A1 (de)
EP (1) EP0431135B1 (de)
JP (2) JP3573454B2 (de)
AT (1) ATE235558T1 (de)
AU (2) AU5856790A (de)
CA (1) CA2019676C (de)
DE (1) DE69034053T2 (de)
DK (1) DK0431135T3 (de)
ES (1) ES2194834T3 (de)
WO (1) WO1991000359A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0500799B1 (de) 1989-11-16 1998-01-14 Duke University Transformation von tierischen Hautzellen mit hilfe von Partikeln
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
EP0531506B2 (de) * 1991-03-06 2003-05-21 Monsanto Company Partikel-auslösende transformation von baumwolle
CA2098498A1 (en) * 1991-10-15 1993-04-16 Ning-Sun Yang Particle-mediated transformation of mammalian unattached cells
WO1993008292A1 (en) * 1991-10-16 1993-04-29 Agracetus, Inc. Particle-mediated transformation of animal somatic cells
US5260191A (en) * 1992-01-30 1993-11-09 Agracetus, Inc. Method for diagnosing tumors
EP0584339A4 (en) * 1992-03-04 1996-02-28 Jon A Wolff Method of delivering therapeutic substances to the brain
ES2242954T3 (es) * 1992-03-11 2005-11-16 Powderject Vaccines, Inc. Vacuna genetica para el virus de la inmunodeficiencia.
WO1993024626A1 (en) * 1992-05-28 1993-12-09 Scientific Dimensions Usa, Inc. Transgenic animal production with biolistically transformed spermatozoa
EP0706576A1 (de) * 1993-06-30 1996-04-17 Dcv Biologics L.P. Eine methode zur ineinfühlung von einem biologische stoff in ein ziel
GB2282139A (en) * 1993-09-24 1995-03-29 Univ Reading Introducing DNA into the germ line of birds
US6995008B1 (en) 1994-03-07 2006-02-07 Merck & Co., Inc. Coordinate in vivo gene expression
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
AU711915B2 (en) * 1995-12-21 1999-10-21 Dimminaco Ag Plasmid vaccine against pseudorabies virus
BE1010344A3 (fr) * 1996-06-12 1998-06-02 Solvay Vaccin plasmidique contre le virus pseudorabique.
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
CA2340330A1 (en) 1998-08-20 2000-03-02 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein c of chlamydia
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
US7022320B1 (en) 1999-02-09 2006-04-04 Powderject Vaccines, Inc. Mycobacterium tuberculosis immunization
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
EP1792995A3 (de) 2000-05-08 2007-06-13 Sanofi Pasteur Limited Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
EP1282702B1 (de) 2000-05-10 2006-11-29 Sanofi Pasteur Limited Durch mage minigene kodierte immunogene polypeptide und ihre verwendungen
GB0201736D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd DNA dosage forms
ATE357219T1 (de) * 2002-01-25 2007-04-15 Glaxo Group Ltd Darreichungsformen für dns
EP1356820A1 (de) 2002-04-26 2003-10-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) DNA-Impfstoff kombiniert mit einen Apoptoneauslöser von Tumorzellen
ES2548987T3 (es) 2009-03-27 2015-10-22 Christine Chomienne Ácido nucleico antisentido de kanamicina para el tratamiento del cáncer
WO2011154863A1 (en) 2010-06-07 2011-12-15 Pfizer Inc. Her-2 peptides and vaccines
US20220135937A1 (en) 2018-12-20 2022-05-05 National University Corporation Toyohashi University Of Technology Electroporation device and method for producing cells with introduced foreign substance
IT201900007060A1 (it) 2019-05-21 2020-11-21 St Superiore Di Sanita Cellule tumorali ingegnerizzate e loro usi
IT201900012540A1 (it) 2019-07-22 2021-01-22 Humanitas Mirasole Spa Inibitori di CHI3L1 e loro usi
US11319613B2 (en) 2020-08-18 2022-05-03 Enviro Metals, LLC Metal refinement

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
IL84459A (en) * 1986-12-05 1993-07-08 Agracetus Apparatus and method for the injection of carrier particles carrying genetic material into living cells
US5015580A (en) * 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
US5405779A (en) * 1993-04-09 1995-04-11 Agracetus, Inc. Apparatus for genetic transformation
US5506125A (en) * 1993-12-22 1996-04-09 Agracetus, Inc. Gene delivery instrument with replaceable cartridges

Also Published As

Publication number Publication date
EP0431135B1 (de) 2003-03-26
AU5856790A (en) 1991-01-17
ES2194834T3 (es) 2003-12-01
WO1991000359A1 (en) 1991-01-10
JPH04500314A (ja) 1992-01-23
US20050216959A1 (en) 2005-09-29
AU5787394A (en) 1994-05-19
JP2001213807A (ja) 2001-08-07
DK0431135T3 (da) 2003-07-21
EP0431135A1 (de) 1991-06-12
JP3573454B2 (ja) 2004-10-06
CA2019676C (en) 2005-08-09
US20020081739A1 (en) 2002-06-27
DE69034053D1 (de) 2003-04-30
AU679477B2 (en) 1997-07-03
CA2019676A1 (en) 1990-12-26
ATE235558T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
DE69034053D1 (de) Transformation von tierischen somatischen zellen mittels partikeln
BRPI0411817A (pt) aparelho e método para estimulação bioelétrica, aceleração da cura, alìvio da dor ou desvitalização de patógenos
DE69230993T2 (de) Rekombinante viren vektoren zur expression in muskelzellen
ES2116986T3 (es) Composiciones de metal-peptidos y metodos cosmeticos para estimular el crecimiento del cabello.
DE69324680D1 (de) Elektrische stimulierung zur behandlung von inkontinenz und anderen neuromuskularerkrankungen
DK0400958T3 (da) Levende vacciner
BR0207399A (pt) Método de terapia com células para o tratamento de tumores
DE3876756D1 (de) Vorrichtung zur gesteuerten freigabe und verabreichung von wirkstoffen an tierisches gewebe.
Bullmann et al. A transportable, inexpensive electroporator for in utero electroporation
ATE290789T1 (de) Verwendungsmethoden von einkernigen phagozyten zur förderung der axonalen regeneration
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
NO932101L (no) Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker
Bravo et al. Microcurrent stimulates cell proliferation and modulates cytokine release in fibroblast cells
CN111172151A (zh) 一种电信号通过调节皮肤DCs/LCs提呈至T细胞而调控机体免疫反应的方法及其用途
HARTLEY et al. Experimental osteogenesis in rabbit muscle
SU1713600A1 (ru) Способ лечени диспепсии жвачных животных
Tenforde Biological effects of extremely-low-frequency magnetic fields
Tas et al. Investigación de los Efectos Neurorregenerativos de Biorresonancia y Magnetoterapia en Ratas Inducidas por Daño del Nervio Ciático
Anisimov Action of direct current on bone tissue
Legon’kova et al. On the Effect of Products Made from Recombinant Spidroin Protein on Wound Regeneration in an Experiment
Hechavarria The BioDome regenerative sleeve: Biochemical and biophysical stimulation of murine digit regeneration
SU799764A1 (ru) Стимул тор миграции стволовыхКлЕТОК КОСТНОгО МОзгА
RU2169554C1 (ru) Мазь для лечения пиодермий
Cullen The effects of low powered pulsed radio-frequencies on wound healing using'in vivo'and'in vitro'model systems
Currier et al. TNF-α further augments natural killer cells when co-administered with an interferon inducer to irradiated, leukemic, bone-marrow-transplanted mice

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation